The 2022 Summit covers
small molecules and
biologics,
new technologies, concepts and case studies in areas such as:
- Formulation design for poorly soluble compounds
- The potential of nanotechnology for better deliverability
- The latest controlled released technologies
- Improving patient compliance by harnessing data and the latest smart device technology
- Optimising formulations for continuous manufacturing
- Overcoming the blood brain barrier and challenges in oral delivery of biologics
- Reformulation and biosimilars
The 2022 Summit covers small molecules and biologics, new technologies, concepts and case studies in areas such as: